Publication | Closed Access

Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors

AntibioticsMoxifloxacin MonotherapyClinical EpidemiologyRespiratory InfectionAmoxicillin-clavulanate Plus RoxithromycinNonsevere Community-acquired PneumoniaAntimicrobial ChemotherapyInfection ControlMedicineClinical MicrobiologyAntimicrobial Resistance